Top Markets
Coin of the day
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Rang în acțiuni #30839
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Preț acțiune
$0.089
Ultima sincronizare: 2026-08-17
Capitalizare de piață
$15.36M
Schimbare (1 zi)
50.59%
Schimbare (1 an)
111.85%
Țară
US
Tranzacționează Inhibitor Therapeutics, Inc. (INTI)

Categorie

Prețul INTI cu capitalizarea de piață a B
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
INTI
$0.089
Capitalizarea de piață a Inhibitor Therapeutics, Inc.(INTI)
Capitalizare de piață: $15.36M
În anul August 2026, Inhibitor Therapeutics, Inc. are o capitalizare de piață de $15.36M. Acest lucru face ca Inhibitor Therapeutics, Inc. să fie a 30839th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Inhibitor Therapeutics, Inc. din 2003 până în 2026
INTI în comparație cu top 5 cele mai populare stocks
Prețul pentru INTI Activul B Capitalizarea de piață a B Rezultate
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$30,749.66 $15.36M
$5.307T +34,550,085.07%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$26,369.80 $15.36M
$4.551T +29,628,891.27%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$24,072.99 $15.36M
$4.154T +27,048,208.47%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$20,794.30 $15.36M
$3.589T +23,364,277.97%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$16,206.69 $15.36M
$2.797T +18,209,663.87%